Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. - Wikidata - awgldk - TriplyDB

Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.

Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.

http://www.wikidata.org/entity/Q33359998

about

Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment The Videofluorographic Swallowing Study in Rheumatologic Diseases: A Comprehensive Review.The epidemiology of Sjögren's syndrome The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature.Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.Impaired clearance of early apoptotic cells mediated by inhibitory IgG antibodies in patients with primary Sjögren's syndrome.Antibody-secreting cell specificity in labial salivary glands reflects the clinical presentation and serology in patients with Sjögren's syndrome.Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays Primary Sjögren's syndrome: new clinical and therapeutic concepts Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren's syndrome.Introducing polyautoimmunity: secondary autoimmune diseases no longer exist.Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality.A systematic review and meta-analysis of cutaneous manifestations in late- versus early-onset systemic lupus erythematosus Ocular manifestations of systemic lupus erythematosus: a review of the literature Association of Antibodies to Interferon-Inducible Protein-16 With Markers of More Severe Disease in Primary Sjögren's Syndrome.Immunosenescence, aging, and systemic lupus erythematous.Sjögren's syndrome associated with systemic lupus erythematosus.TDP-43 frontotemporal lobar degeneration and autoimmune disease.Multiple autoimmune syndrome with celiac disease.Sjögren's syndrome: An underdiagnosed condition in mixed connective tissue disease.The impact of the EUSCLE Core Set Questionnaire for the assessment of cutaneous lupus erythematosus.Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment.Sjögren's syndrome in older patients: aetiology, diagnosis and management.Genetics of Sjögren's syndrome.Epistasis between the MHC and the RCA alpha block in primary Sjögren syndrome.Primary Sjögren's syndrome with diffuse cystic lung changes developed systemic lupus erythematosus: a case report and literature review Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study.Neuroimmune interactions in Sjögren's syndrome: relationship of exocrine gland dysfunction with autoantibodies to muscarinic acetylcholine receptor-3 and mental health status parameters.Mannose-binding lectin gene polymorphisms in Brazilian patients with systemic lupus erythematosus.Implementation of the Connective Tissue Screening Questionnaire in northeast Pennsylvania to identify comorbidities of connective tissue diseases in subjects with systemic lupus erythematosus.The frequency of sicca symptoms and Sjögren's syndrome in patients with systemic sclerosis.No association of primary Sjögren's syndrome with Fcγ receptor gene variants.Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren's syndrome (secondary Sjögren's syndrome) focusing on autoimmune rheumatic diseases.Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome.Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients with Associated Sjögren's Syndrome: Post-hoc Analyses from the EMBODY Trials.The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study.Unstimulated whole saliva flow rate in relation to sicca symptoms in Hungary.Oral candidiasis in systemic lupus erythematosus.

P2860

Q26778403-BEFD1572-FDCA-4320-8A99-B2FAADFFD52D Q30234992-EFF39251-9D72-41DB-AB9E-D9E2D674EC2A Q33863655-D9C21C7A-0211-4907-8B2C-200E39C53FB2 Q34004258-8BB666FC-5EA5-4BB2-AD31-2561AD771700 Q34240032-A6CCA12F-0518-44EF-ACCA-84B9FA7A1E65 Q34473302-A7642165-6DDF-457D-B31F-CECF7344925A Q34513422-8E46E225-2B08-4196-9254-E5B34983665B Q34577213-41D5213A-3F34-4A7E-83E4-2CBE475AE9CC Q35533123-772169BC-16C9-4016-B6B6-2017BFD7C16E Q35555323-EDAB3BBA-CE61-44B0-9EE3-DB170B1BA089 Q35576410-4EDB8BB3-07DC-4B5F-8EF2-D1C1283CA1B3 Q35791637-D31571C7-8138-4B8F-A96F-A51D75B8BD75 Q35954573-1263CC16-6B9E-4ADF-837C-EE7BD0907006 Q35955580-00D1260F-9604-4A55-BFD7-61706DFDC820 Q36091026-F6E20F1B-F672-498C-A626-C6658E6FD048 Q36842737-E2569F40-BD05-4D37-B161-0D51CD2AF270 Q37292111-71F54C85-1688-4C53-867C-C4538303DD82 Q37305425-F9A66BD1-FC07-496E-BC87-D9FB7173F02A Q37343963-2F5E0C01-E6AA-43AF-8D4C-CF4B0694159D Q37590680-4391488D-3E97-49C5-89C6-E7C34D7CD758 Q37603853-C5BA125F-0AF9-41C0-B62A-D41241A25440 Q37778654-DB0DC2CC-2A2F-4B72-8DA4-F45D2D96B57B Q37845609-72BE0668-C115-4720-AA6F-EA221BA6B815 Q37977481-D2A270DC-E302-44F7-AF65-9116586E0522 Q38076070-84210C23-AC78-4833-A3C4-B48C01A3941D Q39286514-747BFB64-3775-4013-83E3-4C9E718FE5EA Q42128563-16820CCE-D6D9-4955-A5DA-39751F34F6F4 Q42338690-7F2474CF-9C19-4801-A634-7EC29265F4EB Q43245408-BCC60456-E6C9-4446-91E1-5E263C168F26 Q43466473-791D1FD4-F2F3-478E-9135-247E6FA2DF61 Q44807801-8BEDE533-76B6-484E-A9D8-AA1095D0245E Q45249414-DC695A91-6B95-4D98-98BB-93B5BA788E78 Q45780150-B6237017-75D6-45A3-96F0-E7800C9646FC Q46093255-5B7928FF-F221-419C-AEF9-F591B5FFB6C5 Q47634458-C8613647-0D68-445D-9AFA-93D8DF50DDEA Q47780867-46293BF1-B27F-45B5-8704-BAD3C51D7DC5 Q49577334-1E51C13D-30FB-4DA4-9E9B-CC940167CB80 Q50901646-422FC399-E909-464C-8E97-24917301CE48 Q51677871-F606C502-2925-4135-82F4-F436C37C0C80 Q53063788-B3C0C524-A6D5-4619-9159-2ACE43272EF0

P2860

Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.

http://www.wikidata.org/entity/Q33359998

description

2004 nî lūn-bûn

@nan

2004 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մարտին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Sjögren's syndrome associated ...... th primary Sjögren's syndrome.

@ast

Sjögren's syndrome associated ...... th primary Sjögren's syndrome.

@en

type

label

Sjögren's syndrome associated ...... th primary Sjögren's syndrome.

@ast

Sjögren's syndrome associated ...... th primary Sjögren's syndrome.

@en

prefLabel

Sjögren's syndrome associated ...... th primary Sjögren's syndrome.

@ast

Sjögren's syndrome associated ...... th primary Sjögren's syndrome.

@en

P1433

Q33359998-2C8930D2-4854-4EC2-918B-32925DB58FF9

P1476

Q33359998-4580D206-3130-4578-8C05-CB170DB006E3

P2093

Q33359998-02EB270C-0BF6-4325-96C6-490A2962714C

Q33359998-10DACE85-4250-4B43-AE2A-7D6D6B66FE2C

Q33359998-486FA160-C49A-41E4-A58E-C3432F551D46

Q33359998-59553700-BFB7-41CB-825C-8B101600DB08

Q33359998-7639EAB9-6F3E-45B6-90DC-96FC5D967FA0

Q33359998-9D596C94-3AC4-4990-A7DF-FF50934D6D2F

Q33359998-FB9E8276-9868-4799-8A60-B51FB02843EE

P2860

Q33359998-02759C66-9A09-4894-9A3A-9EEE2B09D891

Q33359998-49EAEE42-98DD-45D3-8670-1CB0ECD78FB7

Q33359998-8CF6EE9B-AC25-4996-8ED3-898A1116F565

Q33359998-91D2A49B-24F2-42AF-889A-B10D738F92F0

Q33359998-928AF591-A0FB-4774-9A94-CBF220D35100

Q33359998-B0CE50A4-50D3-46C4-BAEB-3F9C6385F6C9

Q33359998-BDF82675-F613-4341-9C4C-5B72A61148FE

Q33359998-CF3EAF78-804F-4206-A938-2B07FAADF22D

Q33359998-D7700505-304B-42B9-9857-6982B3C14C00

Q33359998-DC9655F3-ABC8-4E89-BCE2-7A17F8346215

P304

Q33359998-6423C0C0-28C3-4CE3-BAD5-2F1CE3D7BC26

P31

Q33359998-87587350-BDA9-4E8D-A68D-15EC242A0494

P356

Q33359998-9267C263-24D7-4AED-9DC1-F2A6F9166F97

P433

Q33359998-5712C1EB-613B-4D22-BA14-3DF3AF4161A3

P478

Q33359998-1859D7C7-6819-4BAC-A406-093E748A6A4E

P577

Q33359998-1D5D9468-0C1A-4E42-BF6D-A38FA6F413DF

P5875

Q33359998-A41E1AC5-31C1-4BAF-AAAC-561F1C6ABA54

P698

Q33359998-E5E62D11-7883-4DBB-B3BC-A971DA2B3823

P356

P1433

Arthritis & Rheumatology

P1476

Sjögren's syndrome associated ...... th primary Sjögren's syndrome.

@en

P2093

Aikaterini Stavropoulou

http://www.w3.org/2001/XMLSchema#string

Chryssoula Georgopoulou

http://www.w3.org/2001/XMLSchema#string

Elias Zintzaras

http://www.w3.org/2001/XMLSchema#string

Fotini N Skopouli

http://www.w3.org/2001/XMLSchema#string

Haralampos M Moutsopoulos

http://www.w3.org/2001/XMLSchema#string

Marilyn Spyropoulou

http://www.w3.org/2001/XMLSchema#string

Menelaos N Manoussakis

http://www.w3.org/2001/XMLSchema#string

P2860

Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus.

Systemic lupus erythematosus VII: frequency and impact of secondary Sjøgren's syndrome.

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables.

Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.

Vasculopathy of the antiphospholipid syndromes revisited: thrombosis is the culprit and vasculitis the consort.

Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis.

The immunogenetic relationship between anti-Ro(SS-A)/La(SS-B) antibody positive Sjögren's/lupus erythematosus overlap syndrome and the neonatal lupus syndrome.

Molecular analysis of HLA class II genes in primary Sjögren's syndrome. A study of Israeli Jewish and Greek non-Jewish patients.

P304

882-891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.20093

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5309173

http://www.w3.org/2001/XMLSchema#string

P698

15022331

http://www.w3.org/2001/XMLSchema#string